<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A close relationship between <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, growth, and <z:e sem="disease" ids="C0205699" disease_type="Neoplastic Process" abbrv="">carcinomatosis</z:e> has been observed </plain></SENT>
<SENT sid="1" pm="."><plain>Netrin-4 (NT-4) has been shown to regulate angiogenic responses </plain></SENT>
<SENT sid="2" pm="."><plain>We aimed to examine the effects of NT-4 on <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumor</z:e> <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, growth, and <z:e sem="disease" ids="C0205699" disease_type="Neoplastic Process" abbrv="">carcinomatosis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We showed that NT-4 was expressed in human <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells (LS174) </plain></SENT>
<SENT sid="4" pm="."><plain>A 20-fold increase in NT-4 expression was stably induced by NT-4 pcDNA in LS174 cells </plain></SENT>
<SENT sid="5" pm="."><plain>In vivo, a Matrigel <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> assay showed that NT-4 overexpression altered vascular endothelial growth factor (VEGF)/basic fibroblast growth factor-induced <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>In <z:mp ids='MP_0003815'>nude</z:mp> mice with LS174 xenografts, NT-4 overexpression inhibited <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> and growth </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, these NT-4-involved inhibitory effects were associated with decreased <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell proliferation and increased <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>Using an orthotopic <z:e sem="disease" ids="C1332128" disease_type="Neoplastic Process" abbrv="">peritoneal carcinomatosis</z:e> model, we demonstrated that NT-4 overexpression decreased <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> <z:e sem="disease" ids="C0205699" disease_type="Neoplastic Process" abbrv="">carcinomatosis</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Moreover, <z:e sem="disease" ids="C0205699" disease_type="Neoplastic Process" abbrv="">carcinomatosis</z:e>-related <z:hpo ids='HP_0001541'>ascites</z:hpo> formation was significantly decreased in mice transplanted with NT-4 LS174 cells versus control LS174 cells </plain></SENT>
<SENT sid="10" pm="."><plain>The antiangiogenic activity of NT-4 was probably mediated by binding to its receptor neogenin </plain></SENT>
<SENT sid="11" pm="."><plain>Netrin-4 had a direct effect on neither in vitro <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and proliferation of cultured LS174 cells nor the VEGF-induced <z:hpo ids='HP_0011009'>acute</z:hpo> increase in vascular permeability in vivo </plain></SENT>
<SENT sid="12" pm="."><plain>We propose that NT-4 overexpression decreases <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> and <z:e sem="disease" ids="C0205699" disease_type="Neoplastic Process" abbrv="">carcinomatosis</z:e>, probably via an antiangiogenic effect, underlying the potential therapeutic interest in NT-4 in the treatment of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> growth and <z:e sem="disease" ids="C0205699" disease_type="Neoplastic Process" abbrv="">carcinomatosis</z:e> </plain></SENT>
</text></document>